|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-3-8
|
|
pubmed:abstractText |
The authors have previously demonstrated that modulation of the growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis can significantly affect meningioma growth in vitro. These studies were performed to evaluate the efficacy of GH receptor blockade in vivo.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0022-3085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
487-92
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11235955-Adult,
pubmed-meshheading:11235955-Aged,
pubmed-meshheading:11235955-Animals,
pubmed-meshheading:11235955-Female,
pubmed-meshheading:11235955-Human Growth Hormone,
pubmed-meshheading:11235955-Humans,
pubmed-meshheading:11235955-Insulin-Like Growth Factor I,
pubmed-meshheading:11235955-Insulin-Like Growth Factor II,
pubmed-meshheading:11235955-Male,
pubmed-meshheading:11235955-Meningeal Neoplasms,
pubmed-meshheading:11235955-Meningioma,
pubmed-meshheading:11235955-Mice,
pubmed-meshheading:11235955-Mice, Nude,
pubmed-meshheading:11235955-Middle Aged,
pubmed-meshheading:11235955-Neoplasm Transplantation,
pubmed-meshheading:11235955-Receptors, Somatotropin
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice.
|
|
pubmed:affiliation |
Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, USA. imccutch@notes.mdacc.tmc.edu
|
|
pubmed:publicationType |
Journal Article
|
